EP 3252070 A1 20171206 - PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
Title (en)
PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN
Title (de)
VERFAHREN UND SYSTEM ZUR GEWINNUNG VON BOTULINUMNEUROTXIN
Title (fr)
PROCÉDÉ ET SYSTÈME PERMETTANT D'OBTENIR DE LA NEUROTOXINE BOTULIQUE
Publication
Application
Priority
- US 50218109 A 20090713
- EP 10733117 A 20100712
- US 2010041745 W 20100712
Abstract (en)
Rapid, animal protein free, chromatographic process and system for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.
IPC 8 full level
C07K 14/33 (2006.01); A61K 38/16 (2006.01); C12N 1/20 (2006.01); C12P 21/02 (2006.01)
CPC (source: CN EP KR US)
A61K 38/16 (2013.01 - KR); B01D 15/361 (2013.01 - EP US); B01D 15/362 (2013.01 - EP US); B01D 15/363 (2013.01 - EP US); C07K 1/00 (2013.01 - KR); C07K 1/18 (2013.01 - KR US); C07K 14/33 (2013.01 - CN EP KR US); C12N 1/20 (2013.01 - KR US); C12N 9/52 (2013.01 - EP US); C12P 21/02 (2013.01 - CN US); C12R 2001/145 (2021.05 - US); C12Y 304/24069 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP)
Citation (applicant)
- US 7445914 B2 20081104 - DONOVAN STEPHEN [US]
- US 7452697 B2 20081118 - LUO MINGJIANG [US], et al
- US 7354740 B2 20080408 - XIANG HUI [US], et al
- US 7160699 B2 20070109 - WANG PING [US], et al
- US 7148041 B2 20061212 - DONOVAN STEPHEN [US]
- US 7189541 B2 20070313 - DONOVAN STEPHEN [US]
- US 60944906 A 20061212
- US 9889608 A 20080407
- US 93268907 A 20071031
- US 93278907 A 20071031
- US 23453708 A 20080919
- US 6558926 B1 20030506 - DEMAIN ARNOLD L [US], et al
- US 2003008367 A1 20030109 - OGUMA KEIJI [JP]
- US 2006228780 A1 20061012 - LUO MINGJIANG [US], et al
- US 2003118598 A1 20030626 - HUNT TERRENCE J [US]
- US 6087327 A 20000711 - PEARCE L BRUCE [US], et al
- US 5512547 A 19960430 - JOHNSON ERIC A [US], et al
- US 5756468 A 19980526 - JOHNSON ERIC A [US], et al
- US 5696077 A 19971209 - JOHNSON ERIC A [US], et al
- SCHANTZ E.J. ET AL.: "Therapy with Botulinum Toxin", 1994, MARCEL DEKKER, INC, article "Preparation and characterization of botulinum toxin type A for human treatment", pages: 44 - 45
- SCHANTZ E.J. ET AL.: "Properties and use of botulinum toxin and other microbial neurotoxins in medicine", MICROBIOL REV, vol. 56, no. 1, March 1992 (1992-03-01), pages 80 - 99
- SCHANTZ E.J. ET AL.: "Neurological Disease and Therapy. Therapy with botulinum toxin", 1994, MARCEL DEKKER, article "Preparation and characterization of botulinum toxin type A for human treatment", pages: 41 - 49
- SCHANTZ E.J. ET AL.: "Biomedical Aspects of Botulism", 1981, ACADEMIC PRESS, article "Use of crystalline type A botulinum toxin in medical research", pages: 143 - 150
- OZUTSUMI K. ET AL.: "Rapid, simplified method for production and purification of tetanus toxin", APP & ENVIRON MICRO, vol. 49, no. 4, April 1985 (1985-04-01), pages 939 - 943, XP055348397
- SCHMIDT J.J. ET AL.: "Purification of type E botulinum neurotoxin by highperformance ion exchange chromatography", ANAL BIOCHEM, vol. 156, no. 1, July 1986 (1986-07-01), pages 213 - 219
- SIMPSON L.L. ET AL.: "Methods in Enzymology. Vol. 165, Microbial Toxins: Tools in Enzymology", vol. 165, 1988, ACADEMIC PRESS, article "Isolation and characterization of the botulinum neurotoxins", pages: 76 - 85
- ZHOU L. ET AL.: "Expression and purification of the light chain of botulinum neurotoxin A: A single mutation abolishes its cleavage of SNAP-25 and neurotoxicity after reconstitution with the heavy chain", BIOCHEMISTRY, vol. 34, no. 46, 1995, pages 15175 - 15181, XP002015939, DOI: doi:10.1021/bi00046a025
- KANNAN K. ET AL.: "Methods development for the biochemical assessment of Neurobloc (botulinum toxin type B)", MOV DISORD, vol. 15, no. 2, 2000, pages 20
- WANG Y-C: "The preparation and quality of botulinum toxin type A for injection (BTXA) and its clinical use", DERMATOL LAS FACI COSM SURG, vol. 58, 2002
- JOHNSON S.K. ET AL.: "Scale-up of the fermentation and purification of the recombination heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastoris", PROTEIN EXPR AND PURIF, vol. 32, 2003, pages 1 - 9, XP004469378, DOI: doi:10.1016/j.pep.2003.07.003
- LJUNGDAHL ET AL.: "Manual of industrial microbiology and biotechnology", 1986, AMERICAN SOCIETY FOR MICROBIOLOGY, pages: 84
- GOODNOUGH, M. C., THESIS, 1994
Citation (search report)
- [ID] US 2006228780 A1 20061012 - LUO MINGJIANG [US], et al
- [I] WO 2006096164 A1 20060914 - ALLERGAN INC [US], et al
- [I] GIMENEZ J. ET AL.: "SIMPLIFIED PURIFICATION METHOD FOR CLOSTRIDIUM BOTULINUM TYPE E TOXIN", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 53, no. 12, 1 January 1987 (1987-01-01), pages 2827 - 2830, XP002343950
- [I] SIMPSON L L ET AL: "ISOLATION AND CHARACTERIZATION OF THE BOTULINUM NEUROTOXINS", METHODS IN ENZYMOLOGY, ACADEMIC PRESS, US, vol. 165, 1 January 1988 (1988-01-01), pages 76 - 85, XP002919764, ISSN: 0076-6879, DOI: 10.1016/S0076-6879(88)65015-4
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
US 2011008843 A1 20110113; US 8129139 B2 20120306; AU 2010273601 A1 20120202; BR 112012000784 A2 20200811; CA 2767760 A1 20110120; CA 2767760 C 20181204; CN 102482332 A 20120530; CN 102482332 B 20160803; CN 106117325 A 20161116; CN 106117325 B 20210810; CY 1119519 T1 20180307; CY 1122567 T1 20210127; DK 2454275 T3 20171023; DK 3252070 T3 20200120; EP 2454275 A1 20120523; EP 2454275 B1 20170712; EP 3252070 A1 20171206; EP 3252070 B1 20191002; EP 3640259 A1 20200422; EP 4141024 A1 20230301; EP 4299070 A2 20240103; EP 4299070 A3 20240327; ES 2643554 T3 20171123; ES 2770031 T3 20200630; HK 1247629 A1 20180928; HU E033888 T2 20180129; HU E047362 T2 20200428; IN 456DEN2012 A 20150515; JP 2012532932 A 20121220; JP 2016028601 A 20160303; JP 2017070291 A 20170413; JP 2020078306 A 20200528; JP 2021193103 A 20211223; JP 2024111147 A 20240816; JP 5887268 B2 20160316; JP 6356651 B2 20180711; JP 6704329 B2 20200603; KR 101667174 B1 20161017; KR 101784532 B1 20171011; KR 101916139 B1 20181108; KR 102344985 B1 20211231; KR 20120105417 A 20120925; KR 20150085140 A 20150722; KR 20170019489 A 20170221; KR 20180122039 A 20181109; KR 20190111161 A 20191001; MX 2012000615 A 20120326; MX 2020009978 A 20201012; MX 340718 B 20160722; PL 2454275 T3 20171229; PL 3252070 T3 20200430; PT 2454275 T 20171023; PT 3252070 T 20200114; RU 2012104778 A 20130820; RU 2561459 C2 20150827; SI 2454275 T1 20171229; SI 3252070 T1 20200331; US 10465178 B2 20191105; US 11124786 B2 20210921; US 11203748 B2 20211221; US 11326155 B2 20220510; US 11518986 B2 20221206; US 11525130 B2 20221213; US 11530400 B2 20221220; US 2012108792 A1 20120503; US 2012123095 A1 20120517; US 2012156756 A1 20120621; US 2012245324 A1 20120927; US 2015184141 A1 20150702; US 2016097045 A1 20160407; US 2017327811 A1 20171116; US 2020071686 A1 20200305; US 2021292727 A1 20210923; US 2022033796 A1 20220203; US 2022145279 A1 20220512; US 2022204958 A1 20220630; US 2022228136 A1 20220721; US 2022251532 A1 20220811; US 2022298496 A1 20220922; US 2023021648 A1 20230126; US 2023029327 A1 20230126; US 2023123158 A1 20230420; US 8324349 B2 20121204; US 8357541 B2 20130122; US 8927229 B2 20150106; US 8932827 B2 20150113; US 9206409 B2 20151208; US 9719076 B2 20170801; WO 2011008713 A1 20110120
DOCDB simple family (application)
US 50218109 A 20090713; AU 2010273601 A 20100712; BR 112012000784 A 20100712; CA 2767760 A 20100712; CN 201080038953 A 20100712; CN 201610487340 A 20100712; CY 171101055 T 20171011; CY 191101367 T 20191231; DK 10733117 T 20100712; DK 17180720 T 20100712; EP 10733117 A 20100712; EP 17180720 A 20100712; EP 19200775 A 20100712; EP 22185200 A 20100712; EP 23194794 A 20100712; ES 10733117 T 20100712; ES 17180720 T 20100712; HK 18107202 A 20180601; HU E10733117 A 20100712; HU E17180720 A 20100712; IN 456DEN2012 A 20120116; JP 2012520707 A 20100712; JP 2015214835 A 20151030; JP 2016219708 A 20161110; JP 2020001854 A 20200109; JP 2021142559 A 20210901; JP 2024098461 A 20240619; KR 20127003603 A 20100712; KR 20157018698 A 20100712; KR 20177003936 A 20100712; KR 20187031605 A 20100712; KR 20197027795 A 20100712; MX 2012000615 A 20100712; MX 2014008854 A 20100712; MX 2020009978 A 20120112; PL 10733117 T 20100712; PL 17180720 T 20100712; PT 10733117 T 20100712; PT 17180720 T 20100712; RU 2012104778 A 20100712; SI 201031560 T 20100712; SI 201031966 T 20100712; US 2010041745 W 20100712; US 201213344399 A 20120105; US 201213344420 A 20120105; US 201213407662 A 20120228; US 201213468889 A 20120510; US 201414561402 A 20141205; US 201514961327 A 20151207; US 201715664456 A 20170731; US 201916673444 A 20191104; US 202117340720 A 20210607; US 202117505537 A 20211019; US 202217579208 A 20220119; US 202217694932 A 20220315; US 202217694962 A 20220315; US 202217732951 A 20220429; US 202217835503 A 20220608; US 202217953789 A 20220927; US 202217953882 A 20220927; US 202218084505 A 20221219